INS and diabetes mellitus: Additional trials are currently ongoing [such as the Finnish Diabetes Prediction and Prevention Project (DIPP)] or planned [Primary Oral/intranasal INsulin Trial (Pre-POINT)] and aim to determine the efficacy of nasal insulin as well as the optimum insulin dose [31,32].